Medicare Part D: a first look at prescription drug plans in 2018 Medicare Part D: a first look at prescription drug plans in 2018

Collection: Health Policy and Services Research Series Title(s): Issue brief (Henry J. Kaiser Family Foundation) Author(s): Cubanski, Juliette, author Damico, Anthony, author Hoadley, Jack, author Orgera, Kendal, author Neuman, Tricia, author Contributor(s): Henry J. Kaiser Family Foundation, issuing body. Publication: Menlo Park, CA : Henry J. Kaiser Family Foundation, October 2017 Language(s): English Format: Text Subject(s): Medicare Part C -- economics Medicare Part C -- statistics & numerical data Medicare Part C -- trends Medicare Part D -- economics Medicare Part D -- statistics & numerical data Medicare Part D -- trends United States Genre(s): Technical Report Abstract: During the Medicare open enrollment period from October 15 to December 7 each year, beneficiaries can enroll in a plan that provides Part D drug coverage, either a stand-alone prescription drug plan (PDP) as a supplement to traditional Medicare, or a Medicare Advantage prescription drug plan (MA-PD), which provides all Medicare-covered benefits including drugs. Part D plans vary in numerous ways that can have a significant effect on an enrollee's out-of-pocket spending, including premiums, deductibles, cost sharing, tier placement, the list of covered drugs, and preferred pharmacies. This issue brief provides an overview of the 2018 Part D PDP landscape, the largest segment of the Part D marketplace, with 20.4 million enrollees in 2017 (excluding enrollees in employer-only PDPs, for whom plan premium and benefits data are unavailable). For detail on the data and methods, see the Methods section. Copyright: Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information) Extent: 1 online resource (1 PDF file (21 pages)) Illustrations: Illustrations NLM Unique ID: 101717210 (See catalog record) Permanent Link: http://resource.nlm.nih.gov/101717210